BMYB34:BVMF
Bristol-Myers Squibb Company BDR
R$ ३३१.९०
arrow_upward
+०.६५%(+२.१५) 1D
सेप्टेम्बर ३०, ११:३१:२५ GMT-३ · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BMYB34...
Mkt. cap
१.२२ खरब
Avg. vol.
३.००
Volume
०.००
52-wk high
R$ ३४७.१५
52-wk low
R$ २२१.७२
Shares outstanding
२.०४ अरब
No. of employees
३२ हजार
Mkt. cap
१.२२ खरब
Avg. vol.
३.००
Volume
०.००
52-wk high
R$ ३४७.१५
52-wk low
R$ २२१.७२
Shares outstanding
२.०४ अरब
No. of employees
३२ हजार
News stories
From web sources and news partners
AD HOC NEWS
·
३ घण्टा पहिले
Bristol Myers Squibb stock gains 0.55 percent after-hours to EUR 53.19
MarketBeat
·
४ घण्टा पहिले
MRA Advisory Group Reduces Holdings in Bristol Myers Squibb Company $BMY
Simply Wall Street
·
२३ घण्टा पहिले
Bristol Myers Squibb (BMY) Expands CAMZYOS Approval, Is The Stock Still A Bargain?
MarketWatch
·
१ दिन पहिले
Bristol Myers Squibb Co. stock outperforms competitors on strong trading day
Profile
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2025, 69% of the company's revenues came from the United States.
The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000. Wikipedia
About Bristol-Myers Squibb Company BDR
CEOChris Boerner
Employees३२.५ हजार
Founded१८८७
Headquartersन्यू योर्क शहर, न्यू योर्क, संयुक्त राज्य अमेरिका
Sector-
Websitebms.com